AMANDA BARRITT: Open Payments
NPI 1114644770 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 46 payments from 17 companies in 2025. Trend: 2023 $692 · 2024 $302 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $310 |
| Medtronic, Inc. | 1 | $164 |
| GENZYME CORPORATION | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| Insmed, Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| United Therapeutics Corporation | 2 | $61 |
| Viatris Specialty LLC | 3 | $55 |
| Verona Pharma, Inc. | 3 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
Products named: FASENRA, INTELLIS ADAPTIVESTIM, DUPIXENT, Arikayce, JASCAYD, Tyvaso, TEZSPIRE, YUPELRI.
Industry payments across OK — which companies pay providers there.
